Recent developments in the pharmacotherapy of alcohol dependence

Journal of Consulting and Clinical Psychology

Volumn 64, Issue 4, 1996, Pages 669-676

  Schuckit, Marc A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALCOHOL; ALDEHYDE DEHYDROGENASE; BUSPIRONE; DISULFIRAM; DOPAMINE; NALTREXONE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; CONFUSION; DEPRESSION; DRUG ALCOHOL INTERACTION; DRUG EFFICACY; HUMAN; NAUSEA; NONHUMAN; PATIENT COUNSELING; PATIENT EDUCATION; REVIEW; VERTIGO;

EID: 0029833283     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.64.4.669     Document Type: Review

References (81)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Annis, H. M., & Peachey, J. E. (1992). The use of calcium carbimide in relapse prevention counselling: Results of a randomized controlled trial. British Journal of Addiction, 87, 63-72.
3. Anton, R. F. (1995). New directions in the pharmacotheray of alcoholism. Psychiatric Annals, 25, 353-362.
4. Anton, R. G., & Moak, D. H. (1994). Carbohydrate-deficient transferrin and γ-glutamyltransferase as markers of heavy alcohol consumption: Gender differences. Alcoholism: Clinical and Experimental Research, 18, 747-754.
5. Azrin, N. H., Sisson, R. W., Meyers, R., & Godley, M. (1982). Alcoholism treatment by disulfiram and community reinforcement therapy. Journal of Behavioral Therapy and Experimental Psychiatry, 13, 105-112.
6. Balldin, J., Berggren, U., Engel, J., Eriksson, M., Härd, E., & Söderpalm, B. (1994). Effect of citalopram on alcohol intake in heavy drinkers. Alcoholism: Clinical and Experimental Research, 18, 1133-1136.
7. Blum, K., Hamilton, M. G., & Wallace, J. E. (1977). Alcohol and opiates: A review of common neurochemical and behavioral mechanisms. In K. Blum (Ed.), Alcohol and opiates: Neurochemical and behavioral mechanisms (pp. 203-236). New York: Academic Press.
8. Borg, V. (1983). Bromocriptine in the prevention of alcohol abuse. Acta Psychiatrica Scandinavica, 68, 100-110.
9. Branchey, L., Davis, W., Lee, K. K., & Fuller, R. K. (1987). Psychiatric complications of disulfiram treatment. American Journal of Psychiatry, 144, 1310-1312.
10. Bruno, F. (1989). Buspirone in the treatment of alcoholic patients. Psychopathology, 22(Suppl.), 49-59.
11. Chick, J., Gough, K., Falkowski, W., Kershaw, P., Hore, B., Mehta, B., Ritson, B., Ropner, R., & Torley, D. (1992). Disulfiram treatment of alcoholism. British Journal of Psychiatry, 161, 84-89.
12. Collins, D. M., & Myers, R. D. (1987). Buspirone attenuates volitional alcohol intake in the chronically drinking monkey. Alcohol, 4, 49-56.
13. Dongier, M., Vachon, L., & Schwartz, G. (1991). Bromocriptine in the treatment of alcohol dependence. Alcoholism: Clinical and Experimental Research, 15, 970-977.
14. Dorus, W., Ostrow, D. G., Anton, R., Cushman, P., Collins, J. F., Schaefer, M., Charles, H. L., Desai, P., Hayashida, M., Malkerneker, U., Willenbring, M., Fiscella, R., & Sather, M. R. (1989). Lithium treatment of depressed and nondepressed alcoholics. Journal of the American Medical Association, 262, 1646-1652.
15. Engel, J. A., Fahlke, C., Hard, E., Johannessen, K., & Svenssonl, S. P. (1992). Serotonergic and dopaminergic involvement in ethanol intake. Clinical Neuropharmacology, 15(Suppl. 1), 64A-65A.
16. Fawcett, J., Clark, D. C., Aagesen, C. A., Pisani, V. D., Tilkin, J. M., Sellers, D., McGuire, M., & Gibbons, R. D. (1987). A double-blind placebo-controlled trial of lithium carbonate therapy for alcoholism. Archives of General Psychiatry, 44, 248-256.
17. Fuller, R. K., Branchey, L., Brightwell, D. R., Derman, R. M., Emrick, C. D., Iber, F. L., James, K. E., Lacoursiere, R. B., Lee, K. K., Lowenstam, I., Maany, I., Neiderhiser, D., Nocks, J. J., & Shaw, S. (1986). Disulfiram treatment of alcoholism: A Veterans Administration cooperative study. Journal of the American Medical Association, 256, 1449-1455.
18. Fuller, R. K., & Gordis, E. (1994). Refining the treatment of alcohol withdrawal. Journal of the American Medical Association, 272, 557-558.
19. Gewiss, M., Heidbreder, C., Opsomer, L., Durbin, P., & De Witte, P. (1991). Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol & Alcoholism, 26, 129-137.
20. Hayashida, M., Alterman, A. I., McLellan, T. O'Brien, C. P., Purtill, J. J., Volpicelli, J. R., Raphaelson, A. H., & Hall, C. P. (1989). Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal sysdrome. New England Journal of Medicine, 320, 358-365.
21. Hesselbrock, M. N. (1986). Childhood behavior problems and adult antisocial personality disorder in alcoholism. In R. E. Meyer (Ed.), Psychopathology and addictive disorders (pp. 78-94). New York: Guilford Press.
22. Hoffman, P. L., & Tabakoff, B. (1985). Ethanol's action on brain biochemistry. In R. T. Tarter & D. H. Van Thiel(Eds.), Alcohol and the brain: Chronic effects (pp. 19-68). New York: Plenum Medical Book.
23. Hyytïa, P., & Sinclair, J. D. (1992). Effect of selective opioid receptor antagonists on alcohol consumption by the high-drinking AA rats. Paper presented at the Sixth Congress of the International Society for Biomedical Research on Alcoholism, Bristol, England.
24. Hyytïa, P., & Sinclair, S. D. (1993). Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcoholism: Clinical and Experimental Research, 17, 631-636.
25. Koob, G. F., & Weiss, F. (1992). Neuropharmacology of cocaine and ethanol dependence. In M. Galanter (Ed.), Recent developments in alcoholism. Alcohol and cocaine: Similarities and differences (Vol. 10. pp. 201-233). New York: Plenum Press.
26. Kornet, M., Goosen, C., & Van Ree, J. M. (1991). Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology, 104, 367-376.
27. Kranzler, H. R., Burleson, J. A., Del Boca, F. K., Babor, T. F., Korner, P., Brown, J., & Bohn, M. J. (1994). Buspirone treatment of anxious alcoholics: A placebo-controlled trial. Archives of General Psychiatry, 51, 720-731.
28. Kranzler, H. R., Burleson, J. A., Korner, P., Del Boca, F. K., Bohn, M. J., Brown, J., & Liebowitz, N. (1995). Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. American Journal of Psychiatry, 152, 391-397.
29. Larson, E. W., Olincy, A., Rummans, T. A., & Morse, R. M. (1992). Disulfiram treatment of patients with both alcohol dependence and other psychiatric disorders: A review. Alcoholism: Clinical and Experimental Research, 16, 125-130.
30. Le, A. D., Quan, B., & Chow, S. (1993). Maintenance of naltrexone (N)-induced reduction in ethanol(E)intake by DGAVP. Alcoholism: Clinical and Experimental Research, 17, 481.
31. Lejoyeux, M., & Ades, J. (1993). Evaluation of lithium treatment in alcoholism. Alcohol & Alcoholism, 28, 273-279.
32. LeMarquand, D., Pihl, R. O., & Benkelfat, C. (1994). Serotonin and alcohol intake, abuse, and dependence: Findings of animal studies. Biological Psychiatry, 36, 395-421.
33. Lhuintre, J. P., Daoust, M., Moore, N. D., Chretien, P., Saligaut, C., Tran, G., Boismare, F., & Hillemand, B. (1985). Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet, i, 1014-1016.
34. Lhuintre, J. P., Moore, N., Tran, G., Steru, L., Langrenon, S., Daoust, M., Parot, P., Ladure, P., Libert, C., Boismare, F., & Hillemand, B. (1990). Acamprosate appears to decrease alcohol intake in weaned alcohelics. Alcohol & Alcoholism, 25, 613-622.
35. Linnoila, M., Eckardt, M., Durcan, M., Lister, R., & Martin, P. (1987). Interactions of serotonin with ethanol: Clinical and animal studies. Psychopharmocology Bulletin, 23, 452-457.
36. Litten, R. Z., & Allen, J. P. (1991). Pharmacotherapies for alcoholism: Promising agents and clinical issues. Alcoholism: Clinical and Experimental Research, 15, 620-633.
37. Ludwig, A. M. (1972). On and off the wagon. Journal of Studies on Alcohol, 33, 91-96.
38. Ludwig, A. M. (1985). Cognitive processes associated with "spontaneous" recovery from alcoholism. Journal of Studies at Alcohol, 46, 53-58.
39. Malcolm, R., Anton, R. F., Randall, C. L., Johnston, A., Brady, K., & Thevos, A. (1992). A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcoholism: Clinical and Experimental Research, 16, 1007-1013.
40. Mason, B. J., & Kocsis, J. H. (1991). Desipramine treatment of alcoholism. Psychopharmacology Bulletin, 27, 170-184.
41. Mason, B. J., Ritvo, E. C., Morgan, R. O., Salvato, F. R., Goldberg, G. Welch, B., & Mantero-Atienza, E. (1994). A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcoholism: Clinical and Experimental Research, 18, 1162-1167.
42. Merry, J., Reynolds, C. M., Bailey, J., & Coppen, A. (1976). Prophylactic treatment of alcoholism by lithium carbonate. A cootrolled study. Lancet, ii, 481-482.
43. Meyer, R. E. (1986). Anxiolytics and the alcoholic patient. Journal of Studies on Alcohol, 47, 269-273.
44. Modell, J. G., Mountz, J. M., Glaser, F. B., & Lee, J. Y. (1993). Effect of haloperidol on measures of craving and impaired control in alcoholic subjects. Alcoholism: Clinical and Experimental Research, 17, 234-240.
45. Myers, R. P., Borg, S.. & Mossberg, R. (1986). Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol, 3, 383-388.
46. Nagel, K., Adler, L. E., Bell, J., Nagamoto, H. T., & Freedman, R. (1991). Lithium carbonate and mood disorder in recently detoxified alcoholics: A double-blind, placebo-controlled pilot study. Alcoholism: Clinical and Experimental Research, 15, 982-990.
47. Naranjo, C. A., Bremner, K. E., & Lanctot, K. L., (1995). Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems, Addiction, 90, 87-99.
48. Naranjo, C. A., Kadlec, K. E., Sanhueza, P., Woodley-Remus, D., & Sellers, E. M. (1990). Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clinical Pharmacology and Therapeutics, 47, 490-498.
49. Naranjo, C. A., Poulos C. X., Bremner, K. E., & Lanctot, K. L., (1992). Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers. Clinical Pharmacology and Therapeutics, 51, 729-739.
50. Naranjo, C. A., Sellers, E. M., Roach, C. A., Woodley, D. V., Sanchez-Craig, M., & Sykora, K. (1984). Zimetidine-induced variations in alcohol intake by non-depressed heavy drinkers. Clinical Pharmacology and Therapeutic, 35, 374-381.
51. Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley, D. V., Kadlec, K., & Sykora, K. (1987). The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clinical Pharmacology and Therapeutics, 41, 266-274.
52. Naranjo, C. A., Sullivan, J. T., Kadlec, K. E., Woodley-Remus, D. V., Kennedy, R. N., & Sellers, E. M. (1989). Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clinical Pharmacology and Therapeutics, 46, 301-309.
53. Olivera, A. A., Sarvis, S., & Heard, C. (1990). Anxiety disorders coexisting with substance dependence: Treatment with buspirone. Current Therapeutic Research, 47, 52-61.
54. O'Malley, S. S., Jaffe, A., Chang, G., Schottenfeld, R. S., Meyer, R. E., & Rounsaville, B. (1992). Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry, 49, 881-887.
55. Paille, F. M., Gudfi, J. D., Perkins, A. C., Royer, R. J., Steru, L., & Parot, P. (1995). Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol, 30, 239-247.
56. Palestine, M. L., & Alatorre, E. (1976). Control of acute alcoholic withdrawal symptoms: A comparative study of haloperidol and chlordiazepoxide. Current Therapeutic Research, 20, 289-299.
57. Pelc, I., Le Bon, O., Verbanck, P., Lehert, P., & Opsomer, L. (1992). Calcium-acetyl-homotaurinate for maintaining abstinence in weaned alcoholic patients: A placebo-controlled double-blind multicenter study. In C. A. Naranjo & E. M., Sellers (Eds.), Novel pharmacological interventions for alcoholism (pp. 348-352). New York: Springer-Verlag.
58. Pond, S. M., Becker, C. E., Vandervoort, R., Phillips, M., Bowler, R. M., & Peck, C. C. (1981). An evaluation of the effects of lithium in the treatment of chronic alcoholism: I. Clinical results. Alcoholism: Clinical and Experimental Research, 5, 247-251.
59. Robins, L. N., Tipp, J., & Przybeck, T. (1991). Antisocial personality. In L. N. Robins & D. A. Regier (Eds.), Psychiatric disorders in America. New York: Free Press.
60. Sass, H., Soyka, M., Mann, K., & Zieglgänsberger, W. (in press). Relapse prevention by acamprosate: Results from a placebo controlled study in alcohol dependence. Archives of General Psychiatry.
61. Satel, S. L., Kosten, T. R., Schuckit, M. A., & Fischman, M. W. (1993). Should protracted withdrawal from drugs be included in DSM-IV? American Journal of Psychiatry, 150, 695-704.
62. 1A receptors. Psychopharmacology, 112, 100-110.
63. Schuckit, M. A. (1985a). The clinical implications of primary diagnostic groups among alcoholics. Archives of General Psychiatry 42, 1043-1049.
64. Schuckit, M. A. (1985b). A one-year follow-up of alcoholics given disulfiram. Journal of Studies on Alcohol, 46, 191-195.
65. Schuckit, M. A. (1995a). Alcohol and alcoholism. In K. J., Isselbacher, E. Braunwald, J. D. Wilson, J. B. Martin, A. S. Fauci, & D. L. Kasper (Eds.), Harrison's principles of internal medicine (13th ed., pp. 2420-2425). New York: McGraw-Hill.
66. Schuckit, M. A. (1995b). Drug and alcohol abuse. A clinical guide to diagnosis and treatment (4th ed.), New York: Plenum Medical Book.
67. Schuckit, M. A., Smith, T. L., Anthenelli, R. M., & Irwin, M. (1993). The clinical course of alcoholism in 636 male inpatients. American Journal of Psychiatry, 150, 786-792.
68. Sellers, E. M., Higgins, G. A., & Sobell, M. B. (1992). 5-HT and alcohol abuse. Trends in Pharmacological Sciences, 13, 69-75.
69. 3 agonist, in alcoholism treatment. Biological Psychiatry, 29(11S), 495S.
70. Sellers, E. M., Sullivan, J. T., Somer, G., & Sykora, K. (1991). Characterization of DSM-III-R criteria for uncomplicated alcohol withdrawal provides an empirical basis for DSM-IV. Archives of General Psychiatry, 48, 442-447.
71. 3 antagonist ondansetron in alcohol abuse and dependence. Alcoholism: Clinical and Experimental Research, 18, 879-885.
72. Shaw, G. K., Waller, S., Majumdar, S. K., Alberts, J. L., Latham, C. J., & Dunn, G. (1994). Tiapride is the prevention of relapse in recently detoxified alcoholics. British Journal of Psychiatry, 165, 515-523.
73. Sobell, L. C., Sobell, M. B., Toneatto, T., & Leo, G. I. (1993). What triggers the resolution of akohol problems without treatment? Alcoholism: Clinical and Experimental Research, 17, 217-224.
74. Soyka, M., Sass, H., & Mann, K. (1994). Acamprosate (calcium-acetylhomotaurinate) increases abstinence rate in weaned alcoholics - Results from a double-blind placebo-controlled study: Preliminary data. Alcoholism: Clinical and Experimental Research, 18, 6-16.
75. Swift, R. M., Wheihan, W., Kuznetsov, O., Buongiorno, G., & Hsuing, H. (1994). Naltrexone-induced alterations in human ethanol intoxication. American Journal of Psychiatry, 151, 1463-1467.
76. Tollefson, G. D., Montague-Clouse, J., & Tollefson, S. L. (1992). Treatment of comorbid generalized anxiety in a recently detoxified alcohol population with a selective serotonergic drug (buspirone). Journal of Clinical Psychopharmacology, 12, 19-26.
77. Volpicelli, J. R., Alterman, A. I., Hayashida, M., &. O'Brien, C. P. (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 49, 876-880.
78. Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986). Naltrexone blocks the post-shock increase of ethanol consumption. Life Science, 38, 841-847.
79. Volpicelli, J. R., O'Brien, C. P., Alterman, A. I., & Hayashida, M. (1990). Naltrexone and the treatment of alcohol dependence. In L. D. Reid (Ed.), Opiods, bulimia and alcoholism (pp. 195-215). New York: Springer-Verlag.
80. Whitworth, A. B., Fischer, F., Lesch, O. M., Nimmerichter, A., Oberbauer, H., Platz, T., Potgieter, A., Walter, H., & Fleischhacker, W. W. (1996). Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet, 347, 1438-1442.
81. Wright, C., Moore, R. D., Grodin, D. M., Spyker, D. A., & Gill, E. V. (1993). Screening for disulfiram-induced liver test dysfunction in an inpatient alcoholism program. Alcoholism: Clinical and Experimental Research, 17, 184-186.